Justine Vivier Chicoteau - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Annales De Pathologie|February 29, 2020

[An unusual digestive complication under anti-PD-1 (pembrolizumab)]Julien Calvani, Rémie Elia, Maxime Battistella, et al.

Bulletin Du Cancer|November 27, 2025

[Upper-gastrointestinal tract toxicities associated with Immune Checkpoint Inhibitors (ICI)]Justine Vivier Chicoteau, Lucie Thibault, Pauline Vaflard, et al.

Journal of Crohn'S & Colitis|November 18, 2020

Safety of Hydrocortisone Premedication Discontinuation in Patients with Inflammatory Bowel Disease on Maintenance Therapy with Infliximab: a Prospective Clinical and Pharmacological StudyMy-Linh Tran-Minh, Jean-Marc Gornet, Marianne Maillet, et al.

Gut|July 8, 2022

Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibitionJulie Bonnereau, Tristan Courau, Nicolas Asesio, et al.

Cancer Treatment Reviews|July 1, 2026

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspectiveJudith Raimbourg, Meher Ben Abdelghani, Valerie Boige, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Annales De Pathologie|February 29, 2020

[An unusual digestive complication under anti-PD-1 (pembrolizumab)]Julien Calvani, Rémie Elia, Maxime Battistella, et al.

Bulletin Du Cancer|November 27, 2025

[Upper-gastrointestinal tract toxicities associated with Immune Checkpoint Inhibitors (ICI)]Justine Vivier Chicoteau, Lucie Thibault, Pauline Vaflard, et al.

Journal of Crohn'S & Colitis|November 18, 2020

Safety of Hydrocortisone Premedication Discontinuation in Patients with Inflammatory Bowel Disease on Maintenance Therapy with Infliximab: a Prospective Clinical and Pharmacological StudyMy-Linh Tran-Minh, Jean-Marc Gornet, Marianne Maillet, et al.

Gut|July 8, 2022

Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibitionJulie Bonnereau, Tristan Courau, Nicolas Asesio, et al.

Cancer Treatment Reviews|July 1, 2026

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspectiveJudith Raimbourg, Meher Ben Abdelghani, Valerie Boige, et al.

Pageof 1